IP Rights For AI Computed Dengue Cluster Spatial Simulations.

14 Mar 2026 --
0 Comments

1. Overview: AI and IP in Dengue Cluster Spatial Simulations

AI-computed dengue cluster spatial simulations involve:

AI models: Predicting dengue outbreaks using epidemiological and environmental data

Spatial analysis tools: Geographic Information Systems (GIS) for mapping dengue clusters

Software algorithms: For data processing, modeling, and visualization

Visualization outputs: Heatmaps, charts, and interactive dashboards for public health or research purposes

Key IP issues include:

Authorship – Who owns rights to AI-generated simulation results?

Software protection – Are algorithms, models, and code copyrightable or patentable?

Database rights – Protection of collected epidemiological data (where allowed)

Trade secrets – Proprietary modeling methods or datasets

Derivative works – Using third-party GIS layers, satellite imagery, or epidemiological datasets

Polish law and EU directives guide IP protection, but AI-generated scientific outputs create a gray zone requiring careful legal strategy.

2. Copyright Principles

Under Polish law:

AI cannot be the legal author; humans supervising, curating, or programming the AI must contribute creative control

Copyright does not protect facts, data, or ideas, only the expression of those ideas (e.g., visualization style, code implementation, dashboards)

3. Patent Protection

Patents protect novel, non-obvious, and useful inventions:

Novel AI algorithms for predicting dengue outbreaks

Unique spatial clustering methods or outbreak simulation pipelines

Innovative interfaces for real-time dengue monitoring

4. Key Case Laws

Case 1: Diamond v. Chakrabarty (US, 1980)

Facts: Patent granted for genetically modified bacteria capable of breaking down oil.

Ruling: Human-made inventions are patentable.

Relevance: Novel AI simulation methods for dengue clusters can be patented if they demonstrate technical innovation.

Case 2: Alice Corp. v. CLS Bank International (US, 2014)

Facts: Financial software patent rejected for being an abstract idea.

Ruling: Abstract ideas implemented via computer are not patentable unless they offer technical improvement.

Relevance: AI-based dengue simulations must involve technical innovation (e.g., GIS integration, predictive modeling improvements) to be patentable.

Case 3: Thaler v. Commissioner of Patents (Australia, 2022)

Facts: AI “DABUS” listed as inventor; patent rejected.

Ruling: Only humans can be recognized as inventors.

Relevance: Human developers or epidemiologists must be credited as inventors/authors for AI-based dengue simulation outputs.

Case 4: Feist Publications v. Rural Telephone Service (US, 1991)

Facts: Telephone directory compilation not copyrightable.

Ruling: Copyright requires creative selection/arrangement.

Relevance: Human intervention in selecting data, designing visualizations, or curating AI outputs is essential to claim copyright.

Case 5: SAS Institute Inc. v. World Programming Ltd. (UK, 2013)

Facts: Reimplementation of software functionality without copying code.

Ruling: Only expression, not functionality/ideas, is protected.

Relevance: AI simulation code and visualization can be copyrighted, but underlying epidemiological methods and algorithms are not.

Case 6: Waymo v. Uber (US, 2017)

Facts: Alleged misappropriation of trade secrets.

Relevance: Proprietary AI modeling methods or epidemiological datasets used in dengue simulations may be trade secrets, and misappropriation can lead to legal action.

Case 7: Oracle America, Inc. v. Google LLC (US, 2021)

Facts: Use of Java APIs without a license.

Ruling: Copying substantial portions of code can infringe copyright.

Relevance: Using third-party AI libraries, GIS libraries, or visualization tools for dengue simulations requires proper licensing.

Case 8: European Union Database Directive (1996)

Facts: Protects substantial investment in databases, even if data itself is uncopyrightable.

Relevance: Epidemiological datasets compiled for dengue simulations may be protected as database rights, requiring permission to reuse.

5. Trade Secrets

Trade secrets protect proprietary AI models, predictive parameters, and unique spatial analysis methods.

Must maintain confidentiality and limited access to enforce.

Misappropriation (unauthorized use by competitors or institutions) can be legally actionable.

6. Key IP Strategies for AI Dengue Simulations

Human Authorship Documentation:

Clearly document human contribution in AI model design, visualization choices, and data curation.

Software Licensing Compliance:

Ensure all libraries, GIS layers, and AI tools are licensed appropriately.

Database Rights:

Protect collected datasets under EU database protections, where applicable.

Trade Secret Protection:

Keep AI model parameters, simulation pipelines, and data preparation methods confidential.

Patent Filings:

Consider patent protection for novel simulation algorithms, prediction pipelines, and integration methods.

7. Summary Table: IP Implications

IP Type	Protectable Aspect	Key Case Example(s)	Notes
Patent	Novel AI prediction algorithms, simulation methods	Diamond v. Chakrabarty; Alice Corp; Thaler v. Patents	Must involve technical innovation; human inventors required
Copyright	Code, visualization, dashboards	Feist Publications; SAS Institute; Oracle v. Google	Expression protected; ideas and data are not
Trade Secret	Proprietary models, parameters, pipelines	Waymo v. Uber; Kewanee Oil	Confidentiality must be maintained
Database Rights	Epidemiological datasets	EU Database Directive (1996)	Substantial investment in collecting/organizing data is protected

Key Takeaways

Pure AI-generated dengue simulation outputs cannot claim copyright alone; human involvement is essential.

Technical innovation is required for patent protection.

Licensing, trade secrets, and database rights are critical to protect AI models and data.

Human authorship, proper licensing, and data provenance documentation are crucial in EU/Polish law.